Book a demo

Chemical intelligence powered by cypris.ai

3-(2-aminoethyl)-1H-indole-5,6-diol

3-(2-aminoethyl)-1H-indole-5,6-diol · also: 5,6 Dihydroxytryptamine, 5,6-Dihydroxytryptamine, 3-(2-Aminoethyl)indole-5,6-diol, 3-(2-Amino-ethyl)-1H-indole-5,6-diol, 1H-Indole-5,6-diol, 3-(2-aminoethyl)-, 5-22-12-00350 (Beilstein Handbook Reference)

FormulaC10H12N2O2
Mol. weight192.218
PubChem CID21163
InChIKeySKOKLDQYOKPCPU-UHFFFAOYSA-N
SMILESC1=C2C(=CC(=C1O)O)NC=C2CCN
56Patents
378Research papers
0Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Actelion Pharmaceuticals Ltd20
2Scripps Research Institute5
3JNC Corp4
4L'Oréal SA4
5Novartis AG4
6Medtronic Inc2
7City of Hope1
8University of Florida1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations37
2A61PTherapeutic activity (drug indications)36
3C07DHeterocyclic compounds29
4A61QCosmetics, personal care4
5G01NInvestigating / analysing materials4
6C07KPeptides3
7A61MDevices for introducing media into the body2
8Y02AClimate change adaptation2
9C07BGeneral methods of organic chemistry1
10Y10TCross-reference (technical subjects)1

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Neurotransmitter Receptor Influence on Behavior2
2Acupuncture Treatment Research Studies1
3Epilepsy research and treatment1
4Nausea and vomiting management1
5Neuroscience and Neuropharmacology Research1
6Olfactory and Sensory Function Studies1
7Sulfur Compounds in Biology1

Technology trend analysis

Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.

See Cypris in action

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Anders BjörklundLund University9
2H. G. BaumgartenUniversität Hamburg9
3Kjell HoleUniversity of Bergen7
4Leif WiklundLund University8
5H. P. KlemmUniversität Hamburg6
6Odd‐Geir BergeUniversity of Bergen6
7Berndt EhingerLund University5
8D.B. Beleslin5
9Geoffrey A. HeadBaker Heart and Diabetes Institute5
10H. SchloßbergerMax Planck Institute of Biochemistry5

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of this compound?

The molecular formula is C10H12N2O2 with a molecular weight of 192.218 g/mol.

Which organizations hold the most patents involving this compound?

Actelion Pharmaceuticals Ltd holds the most patents with 20, followed by Scripps Research Institute with 5 patents, and JNC Corp, L'Oréal SA, and Novartis AG each with 4 patents.

What are the primary patent classification areas for this compound?

The compound is primarily classified under A61K (pharmaceutical formulations) with 37 patents, A61P (therapeutic applications) with 36 patents, and C07D (heterocyclic compounds) with 29 patents.

Who are the most prolific authors publishing on this compound?

Anders Björklund and H. G. Baumgarten are the most prolific authors, each with 9 papers. They are followed by Leif Wiklund with 8 papers and Kjell Hole with 7 papers.

What are the common synonyms for this compound?

Common synonyms include 5,6-Dihydroxytryptamine, 3-(2-Aminoethyl)indole-5,6-diol, and 5,6-DHT. The compound is also referenced in the Beilstein Handbook as 5-22-12-00350.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial